HopeStage
Back to all studies
CompletedNCT04243798

Establishing a Dose-response Relationship With Accelerated Transcranial Magnetic Stimulation

Device studyAges 22–65United StatesDepression
The study in practice

Understand this study

Who was this study for?

Listed age limits: 22 years to 65 years.

Listed locations
Stanford, United StatesSee all locations and recruitment
Activities
Device procedures described in the protocol · Sham comparator
Compensation
Payment and expense reimbursement have not been verified.
Study clarity

Study information

Study start dateStarted: June 15, 2021
Recruitment status
Completed
Enrollment listed in the registry
48
Sponsor
Stanford University
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 22 Years to 65 Years
Official registry ID
NCT04243798
Official title
Show the full official title

Utilizing Changes in Human Brain Connectivity to Establish a Dose-response Relationship Involved in the Therapeutic Actions of Prefrontal Brain Stimulation on Depression Symptoms

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Stanford

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Stanford University, a university.

Who was this study for?

Listed age limits: 22 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me